Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
22.00
+0.19 (0.87%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Jade Biosciences Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Jade Biosciences stock have an average target of 48.5, with a low estimate of 40 and a high estimate of 74. The average target predicts an increase of 120.45% from the current stock price of 22.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Jade Biosciences stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 9 | 9 | 9 | 10 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Initiates $45 | Buy | Initiates | $45 | +104.55% | Jun 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $24 → $42 | Buy | Maintains | $24 → $42 | +90.91% | Jun 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $34 → $45 | Buy | Maintains | $34 → $45 | +104.55% | Jun 2, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $32 → $47 | Buy | Reiterates | $32 → $47 | +113.64% | Jun 2, 2026 |
| BTIG | BTIG | Buy Maintains $39 → $74 | Buy | Maintains | $39 → $74 | +236.36% | Jun 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.28
EPS Next Year
-2.28
from -2.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.28 | -2.28 | |
| Avg | -2.28 | -2.28 | |
| Low | -2.28 | -2.28 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.